Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A.M.C. Dingemans; M. Fruh; A. Ardizzoni; B. Besse; C. Faivre-Finn; L.E. Hendriks; S. Lantuejoul; S. Peters; N. Reguart; C.M. Rudin; D. De Ruysscher; P.E. Van Schil; J. Vansteenkiste; M. Reck; ESMO Guidelines Committee

doi:10.1016/j.annonc.2021.03.207

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A.M.C. Dingemans^*
, M. Fruh
, A. Ardizzoni
, B. Besse
, C. Faivre-Finn
, L.E. Hendriks
, S. Lantuejoul
, S. Peters
, N. Reguart
, C.M. Rudin
, D. De Ruysscher
, P.E. Van Schil
, J. Vansteenkiste
, M. Reck
, ESMO Guidelines Committee

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	839-853
Number of pages	15
Journal	Annals of Oncology
Volume	32
Issue number	7
DOIs	https://doi.org/10.1016/j.annonc.2021.03.207
Publication status	Published - 1 Jul 2021

Keywords

2ND-LINE TREATMENT
Clinical Practice Guidelines
LIMITED-STAGE
OPEN-LABEL
PHASE-III TRIAL
PLUS PLATINUM-ETOPOSIDE
PROPHYLACTIC CRANIAL IRRADIATION
QUALITY-OF-LIFE
RADIATION-THERAPY
RTOG 0212
THORACIC RADIOTHERAPY
diagnosis
follow-up
small-cell lung cancer
treatment

Access to Document

10.1016/j.annonc.2021.03.207Licence: Free access - publisher

Cite this

Dingemans, A. M. C., Fruh, M., Ardizzoni, A., Besse, B., Faivre-Finn, C., Hendriks, L. E., Lantuejoul, S., Peters, S., Reguart, N., Rudin, C. M., De Ruysscher, D., Van Schil, P. E., Vansteenkiste, J., Reck, M., & ESMO Guidelines Committee (2021). Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 32(7), 839-853. https://doi.org/10.1016/j.annonc.2021.03.207

@article{357f96eb245542909d81a615fd9ad379,

title = "Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",

keywords = "2ND-LINE TREATMENT, Clinical Practice Guidelines, LIMITED-STAGE, OPEN-LABEL, PHASE-III TRIAL, PLUS PLATINUM-ETOPOSIDE, PROPHYLACTIC CRANIAL IRRADIATION, QUALITY-OF-LIFE, RADIATION-THERAPY, RTOG 0212, THORACIC RADIOTHERAPY, diagnosis, follow-up, small-cell lung cancer, treatment",

author = "A.M.C. Dingemans and M. Fruh and A. Ardizzoni and B. Besse and C. Faivre-Finn and L.E. Hendriks and S. Lantuejoul and S. Peters and N. Reguart and C.M. Rudin and \{De Ruysscher\}, D. and \{Van Schil\}, P.E. and J. Vansteenkiste and M. Reck and \{ESMO Guidelines Committee\}",

year = "2021",

month = jul,

day = "1",

doi = "10.1016/j.annonc.2021.03.207",

language = "English",

volume = "32",

pages = "839--853",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "7",

}

Dingemans, AMC, Fruh, M, Ardizzoni, A, Besse, B, Faivre-Finn, C, Hendriks, LE, Lantuejoul, S, Peters, S, Reguart, N, Rudin, CM, De Ruysscher, D, Van Schil, PE, Vansteenkiste, J, Reck, M & ESMO Guidelines Committee 2021, 'Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up', Annals of Oncology, vol. 32, no. 7, pp. 839-853. https://doi.org/10.1016/j.annonc.2021.03.207

TY - JOUR

T1 - Small-cell lung cancer

T2 - ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

AU - Dingemans, A.M.C.

AU - Fruh, M.

AU - Ardizzoni, A.

AU - Besse, B.

AU - Faivre-Finn, C.

AU - Hendriks, L.E.

AU - Lantuejoul, S.

AU - Peters, S.

AU - Reguart, N.

AU - Rudin, C.M.

AU - De Ruysscher, D.

AU - Van Schil, P.E.

AU - Vansteenkiste, J.

AU - Reck, M.

AU - ESMO Guidelines Committee

PY - 2021/7/1

Y1 - 2021/7/1

KW - 2ND-LINE TREATMENT

KW - Clinical Practice Guidelines

KW - LIMITED-STAGE

KW - OPEN-LABEL

KW - PHASE-III TRIAL

KW - PLUS PLATINUM-ETOPOSIDE

KW - PROPHYLACTIC CRANIAL IRRADIATION

KW - QUALITY-OF-LIFE

KW - RADIATION-THERAPY

KW - RTOG 0212

KW - THORACIC RADIOTHERAPY

KW - diagnosis

KW - follow-up

KW - small-cell lung cancer

KW - treatment

U2 - 10.1016/j.annonc.2021.03.207

DO - 10.1016/j.annonc.2021.03.207

M3 - Article

C2 - 33864941

SN - 0923-7534

VL - 32

SP - 839

EP - 853

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

ER -